Speech-Language Pathologists in Dunn Loring, VA Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Alexandra Sharp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8000 Iliff Dr, Dunn Loring, VA 22027 Phone: 703-560-1000 |
Tiffany Tere' Maher, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8157 Woodland Ct, Dunn Loring, VA 22027 Phone: 703-204-1838 |
Ms. Kimberly Harper, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8000 Iliff Dr, Dunn Loring, VA 22027 Phone: 703-560-1000 |
Ashley Lampe, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8000 Iliff Dr, Dunn Loring, VA 22027 Phone: 703-560-1000 |
News Archive
Nutraceutix receives Chinese patent for probiotic and nutraceutical delivery technology
The Chinese Patent Office has issued Nutraceutix, Inc. patent No. 02823678.5 for BIO-tract. It is the fourth international patent, from many patents pending, that the technology has been awarded recently based on BIO-tract's ability to protect sensitive ingredients such as probiotic organisms from stomach acid on their way to optimal release sites in the intestinal tract.
Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).
Experts explain pros and cons of over-the-counter enzymes
Enzyme supplements available without a prescription are becoming increasingly popular, but should everyone add them to their shopping list? Brent Bauer, M.D., director of the Mayo Clinic Complementary and Integrative Medicine Program, is co-author of a new paper in the medical journal Mayo Clinic Proceedings on the pros and cons of over-the-counter enzymes.
Metabolic Research announces extension of distribution contract with General Nutrition
Metabolic Research, Inc. announced a one year extension of its exclusive distribution contract with General Nutrition Corporation.
Genetic variants linked with greater risk for radiation-driven side effects in cancer patients
Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study published this week in Nature Genetics.
› Verified 4 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Occupational Therapists